CNBC Talking Heads say Hysteria over Swine Flu could bring Profits to Traders

[KoKo]

Apparently cruise lines, hotels, airlines are all taking a dive but any stocks related to Flu Drugs or preventives (masks, handwipes,etc.) are way up. If the "Pandemic" doesn't pan out then the Shorts will have a nice profit from all of this.

Also saying the hysteria overnight sent "world markets crashing in fear, but there has been a slight recovery as the numbers of population coming down with flu, so far aren't as high as expected.

[nadinbrzezinski]

1. Well CNBC , we know this from the expose by Stewart

so I am not shocked

[lame54]

2. expected by who?

[NashVegas]

3. Tis True

http://uk.reuters.com/article/newsOne/idUKN2445216420090424

The swine flu outbreak is likely to benefit one of the most prolific and successful venture capital firms in the United States: Kleiner Perkins Caufield & Byers, Thomson Reuters Private Equity Week reported on Friday.

Shares of the two public companies in the firm's portfolio of eight Pandemic and Bio Defense companies -- BioCryst Pharmaceuticals (BCRX.O) and Novavax (NVAX.O) -- jumped Friday on news that the swine flu killed a reported 60 people in Mexico and has infected people in the United States.

The World Health Organization said the virus appears to be susceptible to Roche's (ROG.VX) flu drug Tamiflu, also known as oseltamivir, but not to older flu drugs such as amantadine.

Shares of Swiss drugmaker Roche Holding AG closed up 3.48 percent after falling sharply earlier in the week on a cancer drug disappointment, while shares of U.S. biotechnology company Gilead Sciences Inc (GILD.O), which gets royalties from Roche on Tamiflu sales, slipped 10 cents to $45.80 on Friday.

But BioCryst, a maker of drugs that block key enzymes in viral diseases, jumped more than 26 percent on Friday to $2.21 per share. Viral vaccine maker Novavax rose more than 75 percent to $1.42 per share.

Right now it might still be a good time to sell or short. I'd check though.